Carregant...
Profile of adverse events following immunization with measles rubella vaccine at a tertiary care hospital in East Delhi, India
BACKGROUND: As a part of a measles and rubella (MR) campaign, the MR vaccine replaced the two-dose measles vaccine at 9–12 months and 16–24 months of age under the Universal Immunization Program (UIP). Although adverse events following immunization (AEFIs) following the measles and MMR vaccine at 9 ...
Guardat en:
| Publicat a: | Ther Adv Vaccines Immunother |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7343355/ https://ncbi.nlm.nih.gov/pubmed/32685913 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2515135520940131 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|